ImmunoGen Inc (IMGN) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for IMGN were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR (2026-04-11) ↗
IMGN is tracked by BiotechSigns with a current catalyst score of 42/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.
ImmunoGen Inc (IMGN) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for IMGN were recorded at the SEC in the past 30 days[1].